AI assistant
Sending…
Oramed Pharmaceuticals Inc. — Director's Dealing 2004
Jun 3, 2004
6965_dirs_2004-06-03_bd6023c1-7a2d-45b9-a83f-9209871f3e33.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IGUANA VENTURES LTD (IGVL)
CIK: 0001176309
Period of Report: 2004-05-27
Reporting Person: Lee James G (Director, CEO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10069013 | Direct |
More from Oramed Pharmaceuticals Inc.
Interim / Quarterly Report
2026
May 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Capital/Financing Update
2026
Feb 20
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Jan 29
Major Shareholding Notification
2026
Jan 29
Director's Dealing
2026
Jan 29